Hangzhou Guangkeande Biotechnology Co., Ltd. ( * ) is a high-tech biotech company with intellectual property rights in China and the United States, jointly founded by scientists from MD Anderson, the world-ranked * cancer center, and scientists graduated from Tsinghua University, Zhejiang University, and Harvard University, and invested by two listed companies. Guangkeande works closely with research institutes and universities, specializing in early medical detection and targeted diagnosis and treatment of malignant tumors. It always focuses on malignant tumors and other diseases that seriously affect human life and health, and contributes to the development of human health. The company adheres to the goal of industrializing tumor diagnosis and treatment products with independent intellectual property rights, takes the internationally * cutting-edge biomedical research results as the core, and is based on diagnosis and treatment application platforms suitable for China's national conditions. It always upholds the concept of "research achievement transformation as the foundation, extending life and health", continuously transforms excellent scientific research results, continuously develops tumor diagnosis and treatment technologies and products with core competitiveness, and transforms the latest domestic and foreign diagnosis and treatment technology achievements into clinical diagnosis and treatment products and applications suitable for China's national conditions. The company strives to build a life and health industry platform by introducing overseas technology projects, attract high-quality scientific research projects, build core competitiveness of the enterprise, and develop into a biotech enterprise with first-class international level and outstanding R&D capabilities. The company has carried out close cooperation with many scientific research and clinical institutions such as MD Anderson Cancer Center, Zhejiang University, and affiliated hospitals of Zhejiang University. At the same time, it has reached global strategic cooperation agreements with Thermo Fisher of the United States and Shimadzu Corporation of Japan, carrying out comprehensive cooperation in the introduction of advanced medical equipment, technology, and talent, and gradually building an internationally first-class research, development, and application platform for tumor molecular diagnostic products and molecular targeted anti-tumor drugs.
What does Hangzhou Guangkeande Biotechnology Co., Ltd. require? Who is Guangkeande hiring? Guangkeande recruitment: Sales占比最多占63.9%，其次是Scientific Research占51.3%. What education can get in at Guangkeande? 硕士占比最多占61.3%，其次是本科占26.4%. High education required at Guangkeande? 硕士占61.3%，博士占3%. Work experience required at Guangkeande? 1-3年占比最多占58.4%，其次是不限占21.9%. Where are the job locations at Guangkeande? 杭州占比最多占50.2%，其次是成都占5.9%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
